"In the absence of such evidence, persons with a history of Bell's palsy may receive an mRNA COVID-19 vaccine unless they have a contraindication to vaccination." There have been no cases of Guillain-Barré syndrome reported following the COVID-19 vaccination in either the Pfizer or Moderna trials.